Paris, 7 December 2010
Co-organized with the Société de Chimie Thérapeutique (SCT).
Invited Speakers :
Pierre Rivière (Ferring Research Institute, San Diego, USA);
Jean-Alain Fehrentz (IBMM, Montpellier, France);
Daniel Obrecht (Polyphor, Allschwil, Suisse);
Anders Dyhr Toft (Novo Nordisk, UK / Danemark);
Jorgen Wittendorff (Ferring Pharmaceuticals, Danemark);
Eric Zanelli (Peptimmune, Boston, USA).
